Precision BioSciences Inc. (DTIL)
$8.49
$-0.06
(-0.70%)
As on 26-Aug-2026 16:26EDT
Market cap
$244 Mln
Revenue (TTM)
$45 Mln
P/E Ratio
--
P/B Ratio
5.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.3
-
Debt to Equity
0.5
-
Book Value
$--
-
EPS
$-2.8
-
Face value
--
-
Shares outstanding
27,601,554
8 Years Aggregate
CFO
$-282.74 Mln
EBITDA
$-415.20 Mln
Net Profit
$-491.29 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Precision BioSciences (DTIL)
| 104.1 | 16.5 | 17.4 | 65.5 | -17.8 | -51.5 | -- |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Precision BioSciences (DTIL)
| 9.2 | -64.9 | -69.3 | -83.9 | -11.3 | -40.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Precision BioSciences (DTIL)
|
8.5 | 244.3 | 45.1 | -52.7 | -116.1 | -76.7 | -- | 5.4 |
| 89.1 | 12,304.7 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.4 | |
| 250.3 | 16,614.0 | 1,054.4 | 755.9 | 5.7 | -- | 19.4 | 10.1 | |
| 79.2 | 10,682.6 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.1 | 13,400.0 | 2,435.9 | 860.6 | 31.0 | 43 | 17 | 7.3 | |
| 107.1 | 12,277.1 | 1,663.7 | 413.6 | 36.3 | 430 | 31.2 | 83.9 | |
| 538.9 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 619.1 | 17,326.2 | 2,782.3 | 491.5 | 21.1 | 110.1 | 36.5 | 39.4 | |
| 377.4 | 10,496.2 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 151.5 | 9,985.8 | 282.0 | 82.9 | -28.6 | 11.4 | 147 | 11.6 |
Shareholding Pattern
View DetailsAbout Precision BioSciences (DTIL)
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform... for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Read more
-
President, CEO & Director
Mr. Michael Amoroso
-
President, CEO & Director
Mr. Michael Amoroso
-
Headquarters
Durham, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Precision BioSciences (DTIL)
What is the current share price of Precision BioSciences Inc (DTIL) Today?
The share price of Precision BioSciences Inc (DTIL) is $8.49 (NASDAQ) as of 26-Aug-2026 16:26 EDT. Precision BioSciences Inc (DTIL) has given a return of -17.83% in the last 3 years.
What is the current PB & PE ratio of Precision BioSciences Inc (DTIL)?
Since, TTM earnings of Precision BioSciences Inc (DTIL) is negative, P/E ratio is not available.
The P/B ratio of Precision BioSciences Inc (DTIL) is 5.39 times as on 21-Aug-2026, a 1 premium to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.74 |
0.86 |
2024 |
3.66 |
0.47 |
2023 |
-0.03 |
0.09 |
2022 |
-0.04 |
0.07 |
2021 |
-0.49 |
0.16 |
What is the 52 Week High and Low of Precision BioSciences Inc (DTIL)?
The 52-week high and low of Precision BioSciences Inc (DTIL) are Rs 9.62 and Rs 3.53 as of 27-Aug-2026.
What is the market cap of Precision BioSciences Inc (DTIL)?
Precision BioSciences Inc (DTIL) has a market capitalisation of $ 244 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Precision BioSciences Inc (DTIL)?
Before investing in Precision BioSciences Inc (DTIL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.